The assortment of GLP-1-friendly drinks on the market has grown, but theres ample space on the shelves for more
Rather than treating excess weight as simply a lifestyle issue, healthcare providers increasingly recognize obesity as a complex medical condition influenced by biological, environmental, and behavioral factors
Landmark trials show semaglutide reduces major cardiovascular events by 20%, earning Wegovy an FDA approval for heart risk reduction
Although atrial fibrillation was not a primary endpoint, reported adverse event rates have not shown a clear increase in AF incidence
The reality is that diarrhea affects a significant portion of semaglutide users and it's actually quite predictable based on how this medication works in your body
14 However, in two studies that included participants not enrolled in the SURPASS and SURMOUNT studies, ie, a large number of individuals who switched from other GLP-1 RAs to tirzepatide, those who transitioned from semaglutide experienced greater weight loss with tirzepatide treatment